US Stock MarketDetailed Quotes
AUGX Augmedix
- 2.860
- +0.010+0.35%
Trading Apr 29 14:54 ET
139.40MMarket Cap-6500P/E (TTM)
2.940High2.830Low133.56KVolume2.920Open2.850Pre Close382.14KTurnover0.46%Turnover RatioLossP/E (Static)48.74MShares6.25052wk High5.98P/B82.68MFloat Cap2.61052wk Low--Dividend TTM28.91MShs Float6.250Historical High--Div YieldTTM3.86%Amplitude1.010Historical Low2.861Avg Price1Lot Size
Augmedix Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | (Q1)Mar 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 7.94%-15.44M | 77.82%-973K | 35.06%-2.29M | -26.76%-5.95M | -49.58%-6.22M | 9.78%-16.77M | 16.96%-4.39M | 35.29%-3.53M | -83.98%-4.7M | 21.53%-4.16M |
| Net income from continuing operations | 21.59%-19.17M | 19.77%-4.49M | 19.73%-4.41M | 31.38%-5.03M | 13.05%-5.24M | -40.00%-24.45M | -6.08%-5.6M | -107.56%-5.49M | -58.18%-7.34M | -22.86%-6.03M |
| Operating gains losses | -94.14%64K | -920.00%-41K | --36K | ---- | ---- | 154.52%1.09M | -68.75%5K | --0 | ---- | ---- |
| Depreciation and amortization | 28.27%1.1M | 22.89%306K | 15.14%251K | 21.86%262K | 60.34%279K | 23.88%856K | 48.21%249K | 39.74%218K | 30.30%215K | -13.86%174K |
| Other non cash items | 27.38%1.74M | 160.85%553K | 38.27%495K | 17.58%388K | -34.76%304K | 10.52%1.37M | -60.37%212K | 28.78%358K | -1.20%330K | 423.60%466K |
| Change In working capital | -182.41%-1.82M | 45,325.00%1.82M | -23.70%689K | -536.70%-2.25M | -363.29%-2.08M | 192.75%2.21M | 100.38%4K | 162.84%903K | -61.74%515K | 164.12%790K |
| -Change in receivables | -405.09%-2.4M | 154.95%727K | 94.43%-20K | -548.16%-3.16M | -98.04%58K | 117.74%786K | 16.37%-1.32M | 79.68%-359K | -560.38%-488K | 348.82%2.96M |
| -Change in prepaid assets | -3,970.59%-692K | 49.15%-60K | -82.56%60K | 5.34%-266K | -1,221.05%-426K | 97.99%-17K | 90.47%-118K | 739.02%344K | -184.64%-281K | 100.00%38K |
| -Change in payables and accrued expense | -79.97%253K | -94.74%39K | 27.42%883K | -47.65%456K | -7.86%-1.13M | -49.76%1.26M | -44.75%742K | -10.23%693K | 118.84%871K | -104,400.00%-1.04M |
| -Change in other current liabilities | -30.87%-992K | -83.61%-224K | -28.90%-339K | -11.64%-211K | -18.48%-218K | ---758K | ---122K | ---263K | ---189K | ---184K |
| -Change in other working capital | 113.86%2.01M | 61.82%1.34M | -78.48%105K | 55.32%935K | 62.23%-369K | 148.15%938K | 98.80%825K | 201.04%488K | 18.04%602K | -1,426.56%-977K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 7.94%-15.44M | 77.82%-973K | 35.06%-2.29M | -26.76%-5.95M | -49.58%-6.22M | 9.78%-16.77M | 16.96%-4.39M | 35.29%-3.53M | -83.98%-4.7M | 21.53%-4.16M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -120.53%-3.11M | -101.52%-1.19M | -117.41%-437K | -703.70%-1.3M | 61.81%-173K | -130.44%-1.41M | -214.89%-592K | -91.43%-201K | -0.62%-162K | -188.54%-453K |
| Net PPE purchase and sale | -120.53%-3.11M | -101.52%-1.19M | -117.41%-437K | -703.70%-1.3M | 61.81%-173K | -130.44%-1.41M | -214.89%-592K | -91.43%-201K | -0.62%-162K | -188.54%-453K |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -120.53%-3.11M | -101.52%-1.19M | -117.41%-437K | -703.70%-1.3M | 61.81%-173K | -130.44%-1.41M | -214.89%-592K | -91.43%-201K | -0.62%-162K | -188.54%-453K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 3,606.06%43.37M | 376,771.43%26.38M | 400.00%20K | 1,042.43%11.88M | 39,015.38%5.09M | -103.27%-1.24M | -99.98%7K | 233.33%4K | -2,133.87%-1.26M | -99.29%13K |
| Net issuance payments of debt | 544.44%5M | --0 | --0 | --0 | --5M | -155.31%-1.13M | --0 | --0 | ---1.13M | --0 |
| Net common stock issuance | --38.74M | --26.93M | ---36K | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
| Proceeds from stock option exercised by employees | 1,083.33%355K | 1,614.29%120K | 1,300.00%56K | 1,466.67%94K | 553.85%85K | -80.77%30K | -82.05%7K | -69.23%4K | -94.00%6K | 225.00%13K |
| Net other financing activities | -407.04%-720K | ---665K | --0 | ---- | ---- | 96.75%-142K | --0 | --0 | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 3,606.06%43.37M | 376,771.43%26.38M | 400.00%20K | 1,042.43%11.88M | 39,015.38%5.09M | -103.27%-1.24M | -99.98%7K | 233.33%4K | -2,133.87%-1.26M | -99.29%13K |
| Net cash flow | ||||||||||
| Beginning cash position | -47.13%21.99M | -17.45%22.29M | -17.93%25.26M | -44.19%20.64M | -47.13%21.99M | 81.03%41.59M | 142.82%27M | 84.47%30.78M | 91.26%36.98M | 81.03%41.59M |
| Current changes in cash | 227.84%24.82M | 587.13%24.22M | 27.31%-2.71M | 175.62%4.63M | 71.54%-1.31M | -204.26%-19.42M | -116.31%-4.97M | 33.01%-3.73M | -130.77%-6.12M | -26.52%-4.6M |
| Effect of exchange rate changes | -159.67%-470K | -318.42%-159K | -398.11%-264K | 91.86%-7K | -900.00%-40K | -1,710.00%-181K | -442.86%-38K | -2,550.00%-53K | ---86K | -300.00%-4K |
| End cash Position | 110.76%46.34M | 110.76%46.34M | -17.45%22.29M | -17.93%25.26M | -44.19%20.64M | -47.13%21.99M | -47.13%21.99M | 142.82%27M | 84.47%30.78M | 91.26%36.98M |
| Free cash flow | -2.01%-18.55M | 56.49%-2.17M | 26.85%-2.73M | -49.33%-7.26M | -38.64%-6.39M | 5.32%-18.18M | 8.99%-4.98M | 32.90%-3.73M | -79.03%-4.86M | 15.48%-4.61M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg